<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert C Hyzy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jakob I McSparron, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Polly E Parsons, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H963232811"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Noninvasive ventilation (NIV) refers to the delivery of positive pressure ventilation through a noninvasive interface (eg, nasal mask, face mask, or nasal plugs), rather than an invasive interface (endotracheal tube, tracheostomy).</p><p>NIV can be used as ventilatory support for patients with acute or chronic respiratory failure. The practical aspects of initiating NIV in adult patients with acute respiratory failure are discussed here. The data that support the indications for NIV in adults with acute respiratory failure and the use of NIV for the treatment of chronic respiratory failure (eg, neuromuscular disorders, chest wall disease, or obesity hypoventilation syndrome) are described separately. (See  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a> and  <a class="medical medical_review" href="/z/d/html/5116.html" rel="external">"Noninvasive ventilatory support and mechanical insufflation-exsufflation for patients with respiratory muscle dysfunction"</a> and  <a class="medical medical_review" href="/z/d/html/5114.html" rel="external">"Noninvasive ventilation in adults with chronic respiratory failure from neuromuscular and chest wall diseases: Patient selection and alternative modes of ventilatory support"</a> and  <a class="medical medical_review" href="/z/d/html/7714.html" rel="external">"Noninvasive positive airway pressure therapy for the obesity hypoventilation syndrome"</a>.)</p><p class="headingAnchor" id="H1702519059"><span class="h1">TIMING, SITE, ANCILLARY STAFF</span><span class="headingEndMark"> — </span>When a trial of NIV is indicated for acute respiratory failure, it should be initiated as soon as possible. Delays in NIV implementation result in deterioration and increase the likelihood of NIV failure [<a href="#rid1">1-3</a>].</p><p>Most commonly, NIV is initiated in the emergency department (ED), the intensive care unit, or a specialized respiratory or high/intermediate-care dependency unit. NIV may also be successfully used in the general ward setting [<a href="#rid4">4</a>]. Regardless of the setting, support with appropriate staff knowledgeable and experienced in NIV use is critical to its success. Appropriate use of NIV is often dependent upon bedside experts who ensure the provision of a comfortable snug-fitting interface with minimal air leaks, appropriate initial settings, and patient reassurance with follow-up that comprises frequent check-ins and altered settings, if needed. (See <a class="local">'Initial monitoring and follow-up'</a> below.)</p><p>Although preliminary studies suggest that prehospital NIV administered by emergency medical transport personnel may reduce mortality and/or rates of intubation, data are conflicting and further randomized trials are required before NIV can be routinely recommended in this setting [<a href="#rid5">5-11</a>]. (See  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications", section on 'Acute cardiogenic pulmonary edema (ACPE)'</a>.)</p><p class="headingAnchor" id="H2943101547"><span class="h1">CHOOSING THE COMPONENTS OF NONINVASIVE VENTILATION</span></p><p class="headingAnchor" id="H4217911623"><span class="h2">Ventilator type</span><span class="headingEndMark"> — </span>NIV can be delivered via a standard ventilator available in most intensive care units (ICUs) or via a bedside portable ventilator/NIV machines.</p><p>In most cases, the ventilator choice is determined by the institutional resources, practices, and policies, the location of the service (eg, ward or ICU), chosen mode of ventilation, and the required fraction of inspired oxygen (FiO<sub>2</sub>) [<a href="#rid12">12-14</a>]. Although most newer bedside portable ventilators can deliver several complex modes of ventilation that closely approximate that delivered by standard ICU ventilators, some of the older bedside devices cannot. For patients in whom oxygenation is tenuous, more precise FiO<sub>2</sub> can be delivered via a standard ICU ventilator since many portable ventilators are limited in the flow rate of oxygen that can be delivered. In addition, if hypercapnia is a concern, the dual-limb tubing (separate inspiratory and expiratory tubing) used on standard ventilators and select portable devices minimizes the rebreathing of carbon dioxide (CO<sub>2</sub>) compared with single-limb tubing used on most portable devices (see <a class="local">'Ventilator circuit'</a> below). ICU ventilators also have better monitoring and alarm features (eg, tidal volume, major air leaks, and/or patient disconnection are more readily detected).</p><p class="headingAnchor" id="H947587890"><span class="h2">Interface (mask)</span><span class="headingEndMark"> — </span>NIV can be delivered through several types of interfaces. Straps hold the interface in place and should be adjusted to avoid excess pressure on the nose or face. Generally, the straps should be loose enough to allow one or two fingers to pass between the face and the strap.</p><p>Common interfaces used for NIV in patients with acute respiratory failure include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oronasal mask</strong> – This interface includes the nose and mouth, but not the eyes and is sometimes referred to as a face mask or orofacial mask. It is the mask that is most commonly used in patients with acute respiratory failure for the delivery of NIV  (<a class="graphic graphic_picture graphicRef76935" href="/z/d/graphic/76935.html" rel="external">picture 1</a>) since they are reasonably well tolerated and eliminate CO<sub>2</sub> effectively, provided the mask fit is good  (<a class="graphic graphic_table graphicRef55475" href="/z/d/graphic/55475.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nasal mask</strong> – A nasal mask covers just the nose  (<a class="graphic graphic_picture graphicRef52499" href="/z/d/graphic/52499.html" rel="external">picture 2</a>) and may be an alternative in those who do not tolerate an oronasal mask (eg, if the patient feels an uncomfortable sense of pressure or suffocation). However, NIV delivered by a nasal mask may result in a large air leak through the mouth and interfere with effective ventilation [<a href="#rid15">15</a>]. For those who demonstrate an air leak that interferes with ventilation a chin strap may alleviate the problem.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nasal prongs</strong> – Nasal prongs (nasal pillows) are inserted into the nares  (<a class="graphic graphic_picture graphicRef75445" href="/z/d/graphic/75445.html" rel="external">picture 3</a> and <a class="graphic graphic_picture graphicRef119634" href="/z/d/graphic/119634.html" rel="external">picture 4</a>) and are an option in patients who are intolerant of an oronasal or nasal mask. A chin strap is also often needed to minimize oral air leak.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Full face mask</strong> – A full face mask includes the eyes, nose, and mouth. Although this mask is superior in terms of maximizing the NIV delivered and minimizing air leaks, it often poorly tolerated.</p><p></p><p>Although the following interfaces may be used to deliver NIV, they are less commonly used in patients with acute respiratory failure:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mouth piece</strong> – Mouth pieces are devices that can be inserted into the mouth  (<a class="graphic graphic_picture graphicRef60750" href="/z/d/graphic/60750.html" rel="external">picture 5</a>). However, air leak through the nose can occur unless nasal pledgets are used. These are more commonly used in some patients with chronic respiratory failure due to neuromuscular disorders, but they are less practical for patients with acute respiratory failure. (See  <a class="medical medical_review" href="/z/d/html/5114.html" rel="external">"Noninvasive ventilation in adults with chronic respiratory failure from neuromuscular and chest wall diseases: Patient selection and alternative modes of ventilatory support"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Helmet</strong> – A helmet interface is also available for NIV  (<a class="graphic graphic_figure graphicRef108315" href="/z/d/graphic/108315.html" rel="external">figure 1</a>). The helmet interface allows patients to talk, read, and drink through a straw, while minimizing complications such as skin necrosis, gastric distension, and eye irritation [<a href="#rid16">16-18</a>]. Mechanically, the helmet behaves as a reservoir between the ventilator and the patient. High flow and short inspiratory time are required to pressurize the helmet rapidly. The helmet may also be able to deliver higher levels of positive end-expiratory pressure (PEEP) to improve oxygenation than high flow oxygen delivered via nasal cannulae (HFNC) [<a href="#rid19">19</a>], possibly making it more suitable in those who are PEEP-responsive.</p><p></p><p class="bulletIndent1">Drawbacks of the helmet device include the accumulation of<sub> </sub>CO<sub>2</sub> within the helmet (alleviated by increasing gas flow rates), a level of noise exposure sufficiently high to cause hearing damage, more patient-ventilator asynchrony (due to delayed triggering and cycling), and less relief of inspiratory effort [<a href="#rid20">20-23</a>]. In addition, the actual tidal volume delivered via helmet ventilation is unknown, owing to the distensibility of the device.</p><p></p><p class="bulletIndent1">Helmet use has been proposed for NIV of patients who need droplet precautions (eg, coronavirus disease 2019 [COVID-19]), although this function is unproven [<a href="#rid24">24</a>]. Data have also shown that helmet NIV may reduce the risk of death and intubation in patients with acute hypoxemic respiratory failure when compared with low flow oxygen or NIV via a facemask [<a href="#rid25">25,26</a>]. However, neither mortality nor length of stay were impacted by the use of helmet NIV in a COVID-19 population [<a href="#rid27">27</a>]. Data discussing the potential efficacy of helmet-delivered NIV in patients with acute hypoxemic respiratory failure and acute respiratory distress syndrome (ARDS) in COVID-19 and non-COVID-19 patients are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications", section on 'Hypoxemic nonhypercapnic respiratory failure not due to ACPE'</a> and  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Selecting invasive versus noninvasive ventilation'</a> and  <a class="medical medical_review" href="/z/d/html/131226.html" rel="external">"COVID-19: Respiratory care of the nonintubated hypoxemic adult (supplemental oxygen, noninvasive ventilation, and intubation)", section on 'Noninvasive modalities'</a>.)</p><p></p><p>The efficacy of different interfaces in patients with acute respiratory failure has been examined [<a href="#rid28">28-30</a>]. Three interfaces were compared in a trial that randomly assigned 26 patients with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) complicated by hypercapnia to receive NIV via full-face mask, nasal mask, or nasal prongs (pillows) [<a href="#rid28">28</a>]. Although the full face mask conferred the greatest physiologic improvement, it was poorly tolerated. Nasal masks or plugs were better tolerated. Similar results were found in an observational study of 36 patients with a <strong>do</strong>-<strong>not</strong>-<strong>intubate</strong> order [<a href="#rid29">29</a>]. Another study that randomly assigned 90 patients to nasal or oronasal mask found that more than one-half of patients initially treated using a nasal mask needed to be changed to an oronasal mask, most often due to a significant air leak through the mouth [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H2736804415"><span class="h2">Ventilator circuit</span><span class="headingEndMark"> — </span>Positive pressure and oxygen are delivered via tubing attached to the interface. If a standard mechanical ventilator is used, then high flows up to an FiO<sub>2</sub> of 1 can be effectively delivered, provided air leaks are minimized. However, many portable ventilators can only deliver lower flow (eg, up to 10 or 15 liters of oxygen/minute, although higher flows may be feasible with a helmet interface). Oxygen should be heated and humidified to improve tolerance and prevent mucosal dryness  (<a class="graphic graphic_figure graphicRef116864" href="/z/d/graphic/116864.html" rel="external">figure 2</a>), which is a common complication when the duration of NIV is prolonged [<a href="#rid31">31</a>]. For standard ventilators, typical dual-limb circuitry is used (ie, with inspiratory and expiratory tubing) while portable ventilators typically have a single-limb circuit  (<a class="graphic graphic_figure graphicRef116867" href="/z/d/graphic/116867.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/z/d/html/1656.html" rel="external">"The ventilator circuit"</a>.)</p><p class="headingAnchor" id="H2290000126"><span class="h1">INITIAL SETTINGS</span><span class="headingEndMark"> — </span>There is no universal approach to selecting initial settings for NIV. Selecting appropriate initial settings depends upon the mode selected to deliver NIV, resource availability, clinician and staff expertise, and patient tolerance. In this section, we provide a general guide to selecting initial NIV settings for the commonly used modes in patients with acute respiratory failure. However, one of the key features required for success is adjustment of initial settings and mode (if necessary) to ensure patient comfort and tolerance. This is best achieved at the bedside when experienced staff take the time to provide patient education and reassurance during the initial trial. This individualized approach to initial settings increases the likelihood that a patient will undergo an <strong>adequate</strong> trial of NIV, thereby ensuring either success or failure. Electronic advisory programs that assist in recommending NIV adjustments are investigational [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H2309119765"><span class="h2">Commonly used modes</span><span class="headingEndMark"> — </span>Bilevel NIV (also known as bilevel positive airway pressure [BPAP]) is the most commonly used mode of NIV in patients with acute respiratory failure. BPAP should not be confused with BiPAP; BiPAP refers to a device that provides positive pressure ventilation including BPAP. BPAP is particularly helpful in patients with acute hypercapnic respiratory failure. This includes patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and disorders associated with acute hypoventilation (eg, patients with drug overdose, patients with acute respiratory failure associated with underlying neuromuscular disorders or obesity hypoventilation syndrome [OHS]). Bilevel NIV is also the most commonly used mode in patients with nonhypercapnic hypoxemic acute respiratory failure due to conditions such as pneumonia, early acute respiratory distress syndrome, or asthma.</p><p>Continuous positive airway pressure (CPAP) is most often indicated in patients with acute cardiogenic pulmonary edema but bilevel NIV is an appropriate alternative especially when hypercapnia is present or if CPAP fails.</p><p>Data that support these indications are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a> and  <a class="medical medical_review" href="/z/d/html/3450.html" rel="external">"Treatment of acute decompensated heart failure: Specific therapies", section on 'Supplemental oxygen and assisted ventilation'</a> and  <a class="medical medical_review" href="/z/d/html/1461.html" rel="external">"COPD exacerbations: Management", section on 'Ventilatory support'</a>.)</p><p class="headingAnchor" id="H3268104699"><span class="h3">Bilevel noninvasive ventilation</span><span class="headingEndMark"> — </span>Our suggested protocol for initiating bilevel NIV is outlined in the table  (<a class="graphic graphic_table graphicRef51201" href="/z/d/graphic/51201.html" rel="external">table 2</a>). Bilevel NIV provides inspiratory positive airway pressure (IPAP) and expiratory PAP (EPAP) at two different levels. The difference between IPAP and EPAP ("delta" PAP) determines and directly correlates with the tidal volume delivered. Alveolar ventilation is enhanced by a larger tidal volume (ie, larger "delta" PAP), assuming that the respiratory rate is constant. The patient is spontaneously breathing during bilevel NIV and each breath is supported to the same level.</p><p>In general, we suggest the following initial settings:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bilevel NIV (BPAP) mode in the spontaneous/timed (S/T) setting with a backup rate of 8 to 12 breaths/minute</strong> – Although the spontaneous mode (ie, the patient is supported only during spontaneous breaths) or timed mode (ie, the patient is only supported during timed breaths) can be selected, the S/T setting is most often selected since it ensures that all breaths are supported and that a minimum respiratory rate is provided if the patient hypoventilates for whatever reason.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>IPAP 8 to 12 cm H</strong><strong><sub>2</sub></strong><strong>O</strong> – The IPAP may be titrated upward as tolerated, usually in increments of 2 cm H<sub>2</sub>O, to a maximum of 20 cm H<sub>2</sub>O. Close attention needs to be paid during titration looking for improved dyspnea, decreased respiratory rate, increased tidal volume and minute ventilation, and good patient-ventilator synchrony. An adequate tidal volume that meets the patient’s needs should decrease the work of breathing and also improve alveolar ventilation, thereby treating acute hypercapnia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>EPAP 3 to 5 cm H</strong><strong><sub>2</sub></strong><strong>O</strong> – If oxygenation remains inadequate, the EPAP may also be increased minimally (eg, up to 10 cm H<sub>2</sub>O) but clinicians should be aware that this maneuver may decrease the delivered tidal volume.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fraction of inspired oxygen (FiO</strong><strong><sub>2</sub></strong><strong>) as needed to keep peripheral O</strong><strong><sub>2</sub></strong><strong> saturation (SpO</strong><strong><sub>2</sub></strong><strong>) &gt;90 percent</strong> – The target oxygenation is determined by the underlying disorder. Useful targets are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Fraction of inspired oxygen'</a>.)</p><p></p><p>A similar protocol for bilevel NIV and other forms of NIV used in patients with OHS who have acute hypercapnia are described separately. (See  <a class="medical medical_review" href="/z/d/html/7714.html" rel="external">"Noninvasive positive airway pressure therapy for the obesity hypoventilation syndrome", section on 'Patients with acute hypercapnic respiratory failure and OHS'</a>.)</p><p>The physiology of BPAP is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/1651.html" rel="external">"Modes of mechanical ventilation", section on 'Bilevel positive airway pressure'</a>.)</p><p class="headingAnchor" id="H2907870417"><span class="h3">Continuous positive airway pressure (CPAP)</span><span class="headingEndMark"> — </span>CPAP refers to the delivery of a continuous level of positive airway pressure throughout the respiratory cycle. No additional pressure above the level of CPAP is provided, and patients must initiate all breaths. Although the spontaneous tidal volume is augmented with CPAP, the tidal volume cannot be titrated as effectively as bilevel NIV; thus it is not the optimal mode for treating disorders that require increased alveolar ventilation (ie, disorders associated with acute hypercapnia). However, since CPAP is functionally similar to positive end-expiratory pressure (PEEP), it is typically more effective at improving oxygenation than ventilation. (See  <a class="medical medical_review" href="/z/d/html/1651.html" rel="external">"Modes of mechanical ventilation", section on 'Continuous positive airway pressure'</a> and  <a class="medical medical_review" href="/z/d/html/1642.html" rel="external">"Positive end-expiratory pressure (PEEP)"</a>.)</p><p>In general, we suggest the following initial settings:</p><p class="bulletIndent1"><span class="glyph">●</span>Mode: CPAP</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CPAP level: 5 to 8 cm H<sub>2</sub>O</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>FiO<sub>2</sub>: as needed to keep SpO<sub>2</sub> &gt;90 percent (target range is variable according to the underlying disorder) (see  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Fraction of inspired oxygen'</a>)</p><p></p><p>CPAP may be titrated up to 20 cm H<sub>2</sub>O as tolerated to achieve improvement of dyspnea and decreased respiratory rate. Although higher pressures up to 25 cm H<sub>2</sub>O may be attempted, they are generally poorly tolerated and not every CPAP device can achieve this pressure.</p><p class="headingAnchor" id="H452053486"><span class="h2">Uncommon modes</span><span class="headingEndMark"> — </span>Volume-limited modes and pressure support ventilation (PSV) may be delivered noninvasively. In general, their use is limited to patients with specific requirements or poor tolerance of BPAP or CPAP. However, not all portable NIV ventilators have these modes. So, if volume-limited or pressure supported ventilation is required, switching to a standard ventilator may be necessary.</p><p class="headingAnchor" id="H3700405875"><span class="h3">Volume-limited ventilation in the assist controlled mode (ACVC)</span><span class="headingEndMark"> — </span>ACVC is chosen when patients need a "guaranteed" tidal volume or minimal minute ventilation. Initial settings are similar to those on a standard ventilator, the details of which are provided separately  (<a class="graphic graphic_table graphicRef123028" href="/z/d/graphic/123028.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Volume-limited assist control ventilation'</a>.)</p><p class="headingAnchor" id="H2934151350"><span class="h3">Pressure support ventilation</span><span class="headingEndMark"> — </span>PSV is chosen when patient comfort and synchrony need to be maximized  (<a class="graphic graphic_table graphicRef123028" href="/z/d/graphic/123028.html" rel="external">table 3</a>). Initial settings and titration are similar to those for bilevel NIV (ie, inspiratory support 8 to 12 cm H<sub>2</sub>O [titration to a maximum of 20 cm H<sub>2</sub>O] and PEEP 3 to 5 cm H<sub>2</sub>O with titration to a maximum of 10 cm H<sub>2</sub>O). (See <a class="local">'Bilevel noninvasive ventilation'</a> above and  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Others'</a>.)</p><p class="headingAnchor" id="H3968687032"><span class="h2">Rarely used modes</span><span class="headingEndMark"> — </span>Controlled mechanical ventilation, intermittent mandatory ventilation (IMV), synchronized IMV (SIMV), pressure controlled ventilation, proportional assist ventilation, and neurally adjusted ventilatory assist (NAVA) are rarely used during NIV. Observational data suggest no difference between NIV-pressure support compared with NAVA-NIV [<a href="#rid33">33</a>]. Descriptions of these modes are described separately and may need a standard ICU ventilator for delivery. (See  <a class="medical medical_review" href="/z/d/html/1651.html" rel="external">"Modes of mechanical ventilation"</a>.)</p><p class="headingAnchor" id="H1432316817"><span class="h1">INITIAL MONITORING AND FOLLOW-UP</span><span class="headingEndMark"> — </span>After NIV is initiated, the patient should be observed closely for the first few minutes to troubleshoot any initial problems [<a href="#rid34">34</a>] (see <a class="local">'Trouble shooting dyssynchrony'</a> below). Once the patient is comfortable, vital signs, oxygenation, and mental status are observed for the next one to two hours in a closely monitored setting (see <a class="local">'Trial duration and reassessment'</a> below). At that point, we typically re-evaluate the patient clinically and obtain arterial blood gases. When the patient demonstrates improvement in clinical signs and symptoms and gas exchange, we typically persist with NIV (see <a class="local">'Trial success'</a> below). However, if they do not improve or show signs of deterioration at any time during the trial, NIV should be abandoned and the patient promptly intubated. (See <a class="local">'Trial failure'</a> below.)</p><p class="headingAnchor" id="H3332782244"><span class="h2">Trouble shooting dyssynchrony</span><span class="headingEndMark"> — </span>Many patients do not initially tolerate NIV due to patient discomfort or ventilator dyssynchrony (ie, the phases of ventilator breath do not match that of the patient) [<a href="#rid35">35,36</a>]. Ventilator dyssynchrony may be due to one or more issues including auto-positive end-expiratory pressure (auto-PEEP), reduced flow due to an interface leak, or discomfort and anxiety. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Treat dyssynchrony'</a>.)</p><p>Management involves treating the underlying reason(s). For example:</p><p class="bulletIndent1"><span class="glyph">●</span>Auto-PEEP should be treated (if present) – Depending on the ventilator used, this may involve reduction in respiratory rate and/or tidal volume, raising the inspiratory flow rate, treating the underlying airflow obstruction, when present, and the application of extrinsic PEEP. (See  <a class="medical medical_review" href="/z/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Dynamic hyperinflation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reducing interface leak – A mask leak can increase the time required for the ventilator to achieve its pressure target, prolonging inspiration and causing discomfort. Tightening the straps or changing the mask is typically the first maneuver but, in some cases, changing the mode of ventilation may be needed. For example, pressure-regulated volume-controlled ventilation (rather than flow-limited) may help, although only select standard ventilators are typically capable of delivering time-limited ventilatory modes  (<a class="graphic graphic_table graphicRef123028" href="/z/d/graphic/123028.html" rel="external">table 3</a>) [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/1651.html" rel="external">"Modes of mechanical ventilation", section on 'Pressure-limited ventilation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Improving patient comfort and reducing anxiety – For many patients, careful explanation and reassurance help alleviate fears and anxieties associated with NIV. For ill-fitting masks or local discomfort associated with the interface, switching to an alternate interface may improve comfort and tolerance. For example, patients who feel a sense of pressure or suffocation with an oronasal mask may do better on a nasal mask or pillows with or without chin straps. When these simple adjustments fail, lowering the settings or changing the mode or may help improve tolerance. Sedation is rarely needed. (See <a class="local">'Sedation'</a> below.)</p><p></p><p class="bulletIndent1">When a change in mode is desired for comfort or dyssynchrony, we prefer pressure support ventilation (PSV). PSV allows the patient to trigger each breath and independently regulate the depth and pattern of breathing. It is reasonable to expect that bilevel NIV provides a similar level of comfort, although this has not been studied. Proportional assist ventilation (PAV) or neurally adjusted ventilatory assist (NAVA) may be helpful in patients who do not tolerate PSV or bilevel NIV. PAV has the advantage of having an inspiratory flow and delivered volume that is proportional to the patient's effort. Cessation of inspiration is determined entirely by the patient, allowing the patient to control the entire respiratory cycle [<a href="#rid38">38</a>]. Randomized trials that compared PAV with PSV in patients with acute respiratory failure found that PAV was more comfortable and better tolerated than PSV [<a href="#rid39">39-41</a>]. However, there was no difference in mortality or intubation rates, and experience with PAV as a mode of ventilation is limited. Other retrospective studies suggest minimal differences between PSV and NAVA, although one suggested that PSV may be superior to NAVA [<a href="#rid33">33,42</a>].</p><p></p><p class="headingAnchor" id="H4271329836"><span class="h2">Trial duration and reassessment</span><span class="headingEndMark"> — </span>Most initial trials of NIV should target one to two hours, unless the patient acutely deteriorates during that period. This time-frame is based upon trials in patients with acute hypercapnic hypoxemic respiratory failure (mostly due to acute exacerbations of chronic obstructive pulmonary disease [AECOPD]) [<a href="#rid15">15,43</a>]; these data suggest that improvement of the pH and arterial carbon dioxide tension (PaCO<sub>2</sub>) within 30 minutes to two hours predicts continued success. These data are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Failure of noninvasive ventilation'</a>.)</p><p>In practice, a significant amount of clinical judgement is required when assessing the response to NIV. For example, for patients who do not demonstrate improvement and who have a do-not-intubate order in place, increasing the settings or changing to a full-face mask may be appropriate with a view to re-evaluation in another one to two hours. Similarly, in patients who are minimally improved but in whom further optimization of medical therapy is pending (eg, further diuresis, bronchodilators, inotropic support, or ultrafiltration), it is not unreasonable to persist with NIV provided the delay in administering treatment is relatively short. Some patients may demonstrate partial improvement, such as improved respiratory acidosis but no improvement in oxygenation, in which case increasing the fraction of inspired oxygen (FiO<sub>2</sub>) or switching to a mode that provides PEEP may help.</p><p>There have been efforts to develop prediction tools for NIV failure. One score includes heart rate, acidosis, consciousness, oxygenation, and respiratory rate; a higher score is predictive of NIV failure with good predictive power after one hour of NIV (area under the receiver operating curve [AUC] 0.88) [<a href="#rid44">44</a>]. Physiologic parameters and predictive scores may be integrated into management based on clinical judgement of the providers at the bedside. Further study is needed before this score can be routinely used.</p><p class="headingAnchor" id="H801813954"><span class="h3">Trial success</span><span class="headingEndMark"> — </span>A trial is considered successful when both clinical and gas exchange criteria are improved. In such cases, persisting with NIV and monitoring for another two hours or more for continued success is reasonable. Patients should also be monitored for complications such as aspiration and pressure ulcers. Continued improvement should prompt weaning while deterioration at any point should prompt intubation and mechanical ventilation. (See <a class="local">'Complications'</a> below and <a class="local">'Weaning'</a> below.)</p><p class="headingAnchor" id="H3021496851"><span class="h3">Trial failure</span><span class="headingEndMark"> — </span>If a patient does not improve or deteriorates following a one to two hour trial of NIV, the patient should be considered to have failed NIV and be promptly intubated. Clinical judgement is imperative as no explicit physiologic thresholds are indicative of the need for intubation and invasive mechanical ventilation [<a href="#rid45">45</a>]. Clinical criteria suggesting failure include worsening gas exchange, increasing respiratory rate, worsening encephalopathy or agitation, inability to clear secretions, inability to tolerate any of the interfaces, or hemodynamic instability [<a href="#rid43">43</a>].</p><p>NIV failure rates are high [<a href="#rid43">43,46,47</a>]. Two observational studies found that approximately one-third of patients who received a trial of NIV failed [<a href="#rid48">48-50</a>]. Other observational studies suggest variable rates of NIV failure that may relate to the underlying disorder [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H2136604847"><span class="h2">Weaning</span><span class="headingEndMark"> — </span>A patient is deemed ready to wean when gas exchange and clinical parameters of acute respiratory failure have improved dramatically and the cause of respiratory failure has improved. While there are no universal physiologic parameters that support a readiness for weaning from NIV, we consider the following as reasonable:</p><p class="bulletIndent1"><span class="glyph">●</span>A respiratory rate ≥12 and ≤22 breaths per minute.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral oxygen saturation (SpO<sub>2</sub>) ≥90 percent on ≤60 percent FiO<sub>2</sub> or predicted needs can be met with oxygen delivered via high flow nasal cannulae (HFNC) or low flow oxygen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemodynamic stability (preferably off or on low dose vasopressors and heart rate ≥50 and ≤120 beats per minute).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The pH is preferably &gt;7.25 and the patient should ideally be afebrile, awake and alert, or easily arousable.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Minimal NIV settings (eg, bilevel positive airway pressure 10 cm H<sub>2</sub>O/5 cm H<sub>2</sub>O or continuous positive airway pressure ≤10 cm H<sub>2</sub>O).</p><p></p><p>Similarly, there is no universal protocol for weaning and in general, it is individualized and dependent upon the patient’s response to decreased support. Weaning from NIV may be accomplished by progressively decreasing the amount of positive airway pressure, by permitting the patient to be disconnected from the NIV for progressively longer durations, or a combination of both [<a href="#rid52">52</a>]. For example, some patients may be able to tolerate being off NIV for only one to two hours once or twice in the day while others can discontinue NIV immediately. In contrast, others may require reduced pressure support for 12 to 24 hours before tolerating an "off" period.</p><p class="headingAnchor" id="H1548405417"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>NIV is generally safe. Most complications are local and related to a tightly fitting mask:</p><p class="bulletIndent1"><span class="glyph">●</span>Local skin damage may occur due to the pressure effects of the mask and straps [<a href="#rid53">53</a>]. Cushioning the forehead and the bridge of the nose prior to attaching the mask can decrease the likelihood of these problems. Newer models may have reduced this complication, although evidence to support this observation is lacking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eye irritation, sinus pain, congestion, or epistaxis due to mucosal dryness may occur and require either a lower inspiratory pressure or an oronasal mask rather than a nasal mask. Heated humidification may help prevent this complication.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mild gastric distention occurs frequently but is rarely clinically significant at typical levels of inspiratory pressure. However, vomiting and aspiration can occur occasionally. This complication may be more likely in those with full face or oronasal masks. Routine use of a nasogastric tube is not typically warranted. One case of pneumoperitoneum and percutaneous endoscopic gastrostomy (PEG) tube displacement has been described in association with NIV [<a href="#rid54">54</a>].</p><p></p><p>Anxiety, fear, and claustrophobia are not uncommon during the NIV experience [<a href="#rid55">55</a>]. Many of these feelings may be alleviated by bedside education and reassurance. Sedation is rarely needed. (See <a class="local">'Sedation'</a> below.)</p><p>Delirium is not uncommon in patients undergoing NIV, although it is unknown whether NIV treated patients are at an increased risk of delirium compared with other patients and if there are differences regarding the interface used [<a href="#rid56">56</a>]. The development of delirium in patients treated with NIV has been associated with an increased risk of NIV failure and a higher incidence of intensive care unit and hospital mortality [<a href="#rid57">57</a>].</p><p>Complications related to positive pressure ventilation (eg, barotrauma, hemodynamic instability) are rare during NIV compared with invasive positive pressure ventilation [<a href="#rid58">58</a>]. (See  <a class="medical medical_review" href="/z/d/html/1628.html" rel="external">"Clinical and physiologic complications of mechanical ventilation: Overview"</a>.)</p><p>While older studies reported an association between NIV and myocardial infarction (MI) in patients with acute cardiogenic pulmonary edema (ACPE) [<a href="#rid59">59-61</a>], meta-analyses detected a possible increase in MI risk that was not statistically significant [<a href="#rid62">62,63</a>]. This risk does not generally preclude the use of NIV in patients with ACPE [<a href="#rid64">64</a>].</p><p>A case report of parotitis with prolonged NIV in ACPE use has been described [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H4283664156"><span class="h1">SUPPORTIVE CARE AND PROCEDURES</span></p><p class="headingAnchor" id="H2707519682"><span class="h2">Patient position</span><span class="headingEndMark"> — </span>The patient is preferably in the upright or semi-upright position. However, NIV can be delivered in the supine or Trendelenburg position, if necessary (eg, during procedures such as central venous catheter insertion).</p><p class="headingAnchor" id="H2145008932"><span class="h2">Sedation</span><span class="headingEndMark"> — </span>Sedative and analgesic therapy that decreases respiratory drive may be administered in small doses on an individualized basis. On one hand, such therapy may enhance tolerance of NIV when anxiety or pain is limiting NIV use. On the other hand, sedatives may precipitate worsening respiratory failure or arrest and prompt intubation.</p><p>The risks benefit ratio of sedatives and analgesics for patients with acute respiratory failure on NIV are poorly studied. One prospective observational study reported that, compared with the administration of either a sedative or an analgesic, the combined use of both agents was associated with a five-fold increase in NIV failure (due to worsening respiratory failure) [<a href="#rid66">66</a>]. Single-agent therapy was not associated with adverse outcomes. However, methodologic flaws prohibit firm conclusions from this study. In another meta-analysis of 12 studies, the use of <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">dexmedetomidine</a> reduced the risk of intubation (relative risk [RR] 0.54, 95% CI 0.41-0.71; moderate certainty), delirium (RR 0.34, 95% CI 0.22-0.54, moderate certainty), and intensive care unit length of stay (mean difference -2.40 days, 95% CI -3.51 to -1.29 days; low certainty) [<a href="#rid67">67</a>]. These benefits came at the price of increased incidence of bradycardia (RR 2.80, 95% CI 1.92-4.07; moderate certainty) and hypotension (RR 1.98, 95% CI 1.32-2.98; moderate certainty).</p><p class="headingAnchor" id="H3809181525"><span class="h2">Feeding</span><span class="headingEndMark"> — </span>Patients in acute respiratory failure, particularly those on an orofacial mask, are not typically enterally fed due to the slight increased risk of aspiration that can occur from NIV-related gastric distension. Nasogastric tubes also disrupt the seal in the interface and promote air leaks. If malnutrition is a concern, parenteral feeding is an option. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a>.)</p><p>However, in rare cases, some patients may be allowed to eat small meals during their "off" period when weaning, especially if parenteral feeding is not desirable. Enteral tube feeding (eg, via a nasogastric or gastrostomy tube) is rarely permitted.</p><p class="headingAnchor" id="H1267506148"><span class="h2">Bronchoscopy</span><span class="headingEndMark"> — </span>Bronchoscopy is not typically performed during NIV, most often due to the theoretical risk of precipitating worsening respiratory failure or respiratory arrest that might prompt intubation. However, bronchoscopy is technically feasible and, if necessary, it can be performed using a full face mask with a swivel adapter through which the bronchoscope can pass [<a href="#rid68">68</a>]. In most cases, the bronchoscope is passed through the nose and the airways examined in the usual fashion. The procedure can be performed in the upright or supine position, preferably the former. (See  <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">"Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Procedural technique'</a>.)</p><p class="headingAnchor" id="H27924770"><span class="h2">Nebulizers</span><span class="headingEndMark"> — </span>Ventilator circuits have universal nebulizer or inhaler ports that allow nebulized or inhaled medication to be administered (eg, bronchodilators or antibiotics) [<a href="#rid69">69</a>]. The optimal method of drug delivery to the lung during NIV is unclear. Some experts reduce inspiratory flow during nebulization to maximize drug deposition while others do not change ventilatory settings. Alternatively, some patients may tolerate being off NIV for a short period (a few minutes) while the drug is being nebulized in the standard fashion. No method has been proven superior over another and most institutions develop their own policy such that the clinician should be aware of local practices. (See  <a class="medical medical_review" href="/z/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Bronchodilators'</a> and  <a class="medical medical_review" href="/z/d/html/1461.html" rel="external">"COPD exacerbations: Management", section on 'Hospital-based bronchodilator therapies'</a>.)</p><p class="headingAnchor" id="H803353030"><span class="h2">Suctioning</span><span class="headingEndMark"> — </span>Suctioning is routine during NIV. When needed, patients wearing nasal masks or prongs may be suctioned orally or orotracheally. For patients wearing oronasal or full-face masks, the interface can be temporarily removed for a limited period to allow rapid suctioning or give the patient time to cough and clear their own secretions.</p><p>NIV is relatively contraindicated in patients who need frequent suctioning to clear their own secretions or who are at increased risk of vomiting into an orofacial mask. These and other contraindications are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications", section on 'Contraindications'</a>.)</p><p class="headingAnchor" id="H4145595498"><span class="h2">Circuit</span><span class="headingEndMark"> — </span>Circuit maintenance is similar to that described for patients on mechanical ventilation. (See  <a class="medical medical_review" href="/z/d/html/1656.html" rel="external">"The ventilator circuit"</a>.)</p><p class="headingAnchor" id="H879746292"><span class="h2">Nursing care and travel</span><span class="headingEndMark"> — </span>Routine nursing care such as turning and mouth care can be delivered during NIV. For procedures that require travel (eg, computed tomography imaging), a portable ventilator can be used understanding that settings on many portable devices may not exactly mimic those provided by standard ventilators. Thus, procedures that require travel should be minimized, performed only when absolutely necessary, and trained staff should always accompany the patients (eg, nursing and respiratory therapy).</p><p class="headingAnchor" id="H394557230"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/119337.html" rel="external">"Society guideline links: Noninvasive ventilation in adults"</a>.)</p><p class="headingAnchor" id="H2100821198"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Noninvasive ventilation (NIV) refers to the delivery of positive pressure ventilation through a noninvasive interface (eg, nasal mask, face mask, or nasal plugs), rather than an invasive interface (endotracheal tube, tracheostomy). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing, site, ancillary staff</strong> – Once a patient has been selected to receive a trial of NIV, it should be initiated as soon as possible by staff experienced in its use. NIV is typically initiated in the emergency department (ED), the intensive care unit (ICU), or a specialized respiratory or high dependency unit but may also be successfully used in the general ward setting. Support with appropriate staff knowledgeable and experienced in NIV use is critical to its success. (See <a class="local">'Timing, site, ancillary staff'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Components</strong> – NIV can be delivered via a standard ICU ventilator or a bedside portable ventilator. The oronasal mask  (<a class="graphic graphic_picture graphicRef76935" href="/z/d/graphic/76935.html" rel="external">picture 1</a>) is the most common mask used to deliver NIV, although a nasal mask or prongs  (<a class="graphic graphic_picture graphicRef52499" href="/z/d/graphic/52499.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef75445" href="/z/d/graphic/75445.html" rel="external">picture 3</a>) with or without a chin strap is appropriate alternative when an oronasal mask is not tolerated. Positive pressure and oxygen are delivered via circuit tubing attached to the interface. (See <a class="local">'Choosing the components of noninvasive ventilation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial settings</strong> – Selecting appropriate initial settings depends upon the mode selected to deliver NIV, resource availability, clinician and staff expertise, and patient tolerance. While there is no universal approach to selecting initial settings for NIV, we suggest the following as a guide  (<a class="graphic graphic_table graphicRef51201" href="/z/d/graphic/51201.html" rel="external">table 2</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bilevel positive airway pressure (BPAP) – For patients in whom BPAP is chosen, typical initial settings include (see <a class="local">'Bilevel noninvasive ventilation'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>BPAP mode in the spontaneous/timed (S/T) setting with a backup rate of 8 to 12 breaths/minute</p><p class="bulletIndent3"><span class="glyph">-</span>Inspiratory positive airway pressure 8 to 12 cm H<sub>2</sub>O</p><p class="bulletIndent3"><span class="glyph">-</span>Expiratory positive airway pressure 3 to 5 cm H<sub>2</sub>O</p><p class="bulletIndent3"><span class="glyph">-</span>Fraction of inspired oxygen (FiO<sub>2</sub>) targeting peripheral O<sub>2</sub> saturation (SpO<sub>2</sub>) &gt;90 percent</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continuous positive airway pressure (CPAP) – For patients in whom CPAP is chosen, typical initial settings include (see <a class="local">'Continuous positive airway pressure (CPAP)'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>CPAP at 5 to 8 cm H<sub>2</sub>O</p><p class="bulletIndent3"><span class="glyph">-</span>FiO<sub>2</sub> targeting SpO<sub>2</sub> &gt;90 percent</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other modes</strong> – For patients who require more complex modes of mechanical ventilation (eg, pressure support ventilation or volume-limited ventilation in the assist controlled mode) switching to a standard ventilator may be necessary and settings adjusted according to that mode. (See <a class="local">'Uncommon modes'</a> above and  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Mode-specific settings'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring and follow-up</strong> – After NIV is initiated, the patient should be observed closely for the first few minutes to troubleshoot any initial problems. If needed, the settings can be titrated upward as tolerated. Close attention needs to be paid during titration looking for improved dyspnea, decreased respiratory rate, increased tidal volume and minute ventilation (if being monitored), and good patient-ventilator synchrony.</p><p></p><p class="bulletIndent1">Once the patient is comfortable, vital signs, oxygenation, and mental status are observed for the next one to two hours in a closely monitored setting. At that point, we typically re-evaluate the patient clinically and obtain arterial blood gases. When the patient demonstrates improvement in clinical signs, symptoms, and gas exchange, we typically persist with NIV. We wean from NIV when clinical parameters of acute respiratory failure have improved dramatically and the cause of respiratory failure has improved. However, if the patient does not improve or shows signs of deterioration at any time during the trial, NIV should be abandoned and the patient promptly intubated. (See <a class="local">'Initial monitoring and follow-up'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – NIV is generally safe. Most complications are local and related to the tightly fitting mask. These include local skin ulcerations, nasal and eye irritation and dryness, and gastric distention. Aspiration and complications related to positive pressure ventilation (eg, barotrauma, hemodynamic instability) are rare. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supportive care</strong> <strong>and procedures</strong> – NIV is typically administered in the upright or semi-upright position. Sedative and analgesic therapy that decreases respiratory drive may be administered in small doses on an individualized basis when the benefit of NIV tolerance is thought to outweigh the risk of worsening respiratory failure. Enteral feeding is typically withheld, and while bronchoscopy is technically feasible, many experts, including us, avoid it unless necessary. Nebulized medications, suctioning, circuit maintenance, and nursing care are performed in a similar fashion to that in patients who are intubated. (See <a class="local">'Supportive care and procedures'</a> above.)</p><p></p><p class="headingAnchor" id="H3692473651"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Kristy Bauman, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nava S, Navalesi P, Conti G. Time of non-invasive ventilation. Intensive Care Med 2006; 32:361.</a></li><li><a class="nounderline abstract_t">Collaborative Research Group of Noninvasive Mechanical Ventilation for Chronic Obstructive Pulmonary Disease. Early use of non-invasive positive pressure ventilation for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial. Chin Med J (Engl) 2005; 118:2034.</a></li><li><a class="nounderline abstract_t">Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, et al. Use and outcomes of noninvasive positive pressure ventilation in acute care hospitals in Massachusetts. Chest 2014; 145:964.</a></li><li><a class="nounderline abstract_t">Cabrini L, Landoni G, Bocchino S, et al. Long-Term Survival Rate in Patients With Acute Respiratory Failure Treated With Noninvasive Ventilation in Ordinary Wards. Crit Care Med 2016; 44:2139.</a></li><li><a class="nounderline abstract_t">Thompson J, Petrie DA, Ackroyd-Stolarz S, Bardua DJ. Out-of-hospital continuous positive airway pressure ventilation versus usual care in acute respiratory failure: a randomized controlled trial. Ann Emerg Med 2008; 52:232.</a></li><li><a class="nounderline abstract_t">Roessler MS, Schmid DS, Michels P, et al. Early out-of-hospital non-invasive ventilation is superior to standard medical treatment in patients with acute respiratory failure: a pilot study. Emerg Med J 2012; 29:409.</a></li><li><a class="nounderline abstract_t">Plaisance P, Pirracchio R, Berton C, et al. A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema: physiological and clinical effects. Eur Heart J 2007; 28:2895.</a></li><li><a class="nounderline abstract_t">Goodacre S, Stevens JW, Pandor A, et al. Prehospital noninvasive ventilation for acute respiratory failure: systematic review, network meta-analysis, and individual patient data meta-analysis. Acad Emerg Med 2014; 21:960.</a></li><li><a class="nounderline abstract_t">Bakke SA, Botker MT, Riddervold IS, et al. Continuous positive airway pressure and noninvasive ventilation in prehospital treatment of patients with acute respiratory failure: a systematic review of controlled studies. Scand J Trauma Resusc Emerg Med 2014; 22:69.</a></li><li><a class="nounderline abstract_t">Aguilar SA, Lee J, Dunford JV, et al. Assessment of the addition of prehospital continuous positive airway pressure (CPAP) to an urban emergency medical services (EMS) system in persons with severe respiratory distress. J Emerg Med 2013; 45:210.</a></li><li><a class="nounderline abstract_t">Mal S, McLeod S, Iansavichene A, et al. Effect of out-of-hospital noninvasive positive-pressure support ventilation in adult patients with severe respiratory distress: a systematic review and meta-analysis. Ann Emerg Med 2014; 63:600.</a></li><li><a class="nounderline abstract_t">Liesching T, Kwok H, Hill NS. Acute applications of noninvasive positive pressure ventilation. Chest 2003; 124:699.</a></li><li><a class="nounderline abstract_t">Kacmarek, RM. Characteristics of pressure-targeted ventilators used for noninvasive positive pressure ventilation. Respir Care 1997; 42:380.</a></li><li><a class="nounderline abstract_t">Ferguson GT, Gilmartin M. CO2 rebreathing during BiPAP ventilatory assistance. Am J Respir Crit Care Med 1995; 151:1126.</a></li><li><a class="nounderline abstract_t">Soo Hoo GW, Santiago S, Williams AJ. Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive pulmonary disease: determinants of success and failure. Crit Care Med 1994; 22:1253.</a></li><li><a class="nounderline abstract_t">Antonelli M, Conti G, Pelosi P, et al. New treatment of acute hypoxemic respiratory failure: noninvasive pressure support ventilation delivered by helmet--a pilot controlled trial. Crit Care Med 2002; 30:602.</a></li><li><a class="nounderline abstract_t">Gregoretti C, Confalonieri M, Navalesi P, et al. Evaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study. Intensive Care Med 2002; 28:278.</a></li><li><a class="nounderline abstract_t">Antonelli M, Pennisi MA, Pelosi P, et al. Noninvasive positive pressure ventilation using a helmet in patients with acute exacerbation of chronic obstructive pulmonary disease: a feasibility study. Anesthesiology 2004; 100:16.</a></li><li><a class="nounderline abstract_t">Grieco DL, Menga LS, Raggi V, et al. Physiological Comparison of High-Flow Nasal Cannula and Helmet Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med 2020; 201:303.</a></li><li><a class="nounderline abstract_t">Navalesi P, Costa R, Ceriana P, et al. Non-invasive ventilation in chronic obstructive pulmonary disease patients: helmet versus facial mask. Intensive Care Med 2007; 33:74.</a></li><li><a class="nounderline abstract_t">Patroniti N, Foti G, Manfio A, et al. Head helmet versus face mask for non-invasive continuous positive airway pressure: a physiological study. Intensive Care Med 2003; 29:1680.</a></li><li><a class="nounderline abstract_t">Cavaliere F, Conti G, Costa R, et al. Noise exposure during noninvasive ventilation with a helmet, a nasal mask, and a facial mask. Intensive Care Med 2004; 30:1755.</a></li><li><a class="nounderline abstract_t">Racca F, Appendini L, Gregoretti C, et al. Helmet ventilation and carbon dioxide rebreathing: effects of adding a leak at the helmet ports. Intensive Care Med 2008; 34:1461.</a></li><li><a class="nounderline abstract_t">Cabrini L, Landoni G, Zangrillo A. Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure. Lancet 2020; 395:685.</a></li><li><a class="nounderline abstract_t">Ferreyro BL, Angriman F, Munshi L, et al. Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis. JAMA 2020; 324:57.</a></li><li><a class="nounderline abstract_t">Chaudhuri D, Jinah R, Burns KEA, et al. Helmet noninvasive ventilation compared to facemask noninvasive ventilation and high-flow nasal cannula in acute respiratory failure: a systematic review and meta-analysis. Eur Respir J 2022; 59.</a></li><li><a class="nounderline abstract_t">Arabi YM, Aldekhyl S, Al Qahtani S, et al. Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial. JAMA 2022; 328:1063.</a></li><li><a class="nounderline abstract_t">Navalesi P, Fanfulla F, Frigerio P, et al. Physiologic evaluation of noninvasive mechanical ventilation delivered with three types of masks in patients with chronic hypercapnic respiratory failure. Crit Care Med 2000; 28:1785.</a></li><li><a class="nounderline abstract_t">Lemyze M, Mallat J, Nigeon O, et al. Rescue therapy by switching to total face mask after failure of face mask-delivered noninvasive ventilation in do-not-intubate patients in acute respiratory failure. Crit Care Med 2013; 41:481.</a></li><li><a class="nounderline abstract_t">Girault C, Briel A, Benichou J, et al. Interface strategy during noninvasive positive pressure ventilation for hypercapnic acute respiratory failure. Crit Care Med 2009; 37:124.</a></li><li><a class="nounderline abstract_t">Holland AE, Denehy L, Buchan CA, Wilson JW. Efficacy of a heated passover humidifier during noninvasive ventilation: a bench study. Respir Care 2007; 52:38.</a></li><li><a class="nounderline abstract_t">Tams C, Stephan P, Euliano N, et al. Clinical decision support recommending ventilator settings during noninvasive ventilation. J Clin Monit Comput 2020; 34:1043.</a></li><li><a class="nounderline abstract_t">Hansen KK, Jensen HI, Andersen TS, Christiansen CF. Intubation rate, duration of noninvasive ventilation and mortality after noninvasive neurally adjusted ventilatory assist (NIV-NAVA). Acta Anaesthesiol Scand 2020; 64:309.</a></li><li><a class="nounderline abstract_t">Kramer N, Meyer TJ, Meharg J, et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151:1799.</a></li><li><a class="nounderline abstract_t">Kacmarek RM. NIPPV: patient-ventilator synchrony, the difference between success and failure? Intensive Care Med 1999; 25:645.</a></li><li><a class="nounderline abstract_t">Vignaux L, Vargas F, Roeseler J, et al. Patient-ventilator asynchrony during non-invasive ventilation for acute respiratory failure: a multicenter study. Intensive Care Med 2009; 35:840.</a></li><li><a class="nounderline abstract_t">Calderini E, Confalonieri M, Puccio PG, et al. Patient-ventilator asynchrony during noninvasive ventilation: the role of expiratory trigger. Intensive Care Med 1999; 25:662.</a></li><li><a class="nounderline abstract_t">Vitacca M. New things are not always Better: proportional assist ventilation vs. pressure support ventilation. Intensive Care Med 2003; 29:1038.</a></li><li><a class="nounderline abstract_t">Gay PC, Hess DR, Hill NS. Noninvasive proportional assist ventilation for acute respiratory insufficiency. Comparison with pressure support ventilation. Am J Respir Crit Care Med 2001; 164:1606.</a></li><li><a class="nounderline abstract_t">Wysocki M, Richard JC, Meshaka P. Noninvasive proportional assist ventilation compared with noninvasive pressure support ventilation in hypercapnic acute respiratory failure. Crit Care Med 2002; 30:323.</a></li><li><a class="nounderline abstract_t">Fernández-Vivas M, Caturla-Such J, González de la Rosa J, et al. Noninvasive pressure support versus proportional assist ventilation in acute respiratory failure. Intensive Care Med 2003; 29:1126.</a></li><li><a class="nounderline abstract_t">Tajamul S, Hadda V, Madan K, et al. Neurally-Adjusted Ventilatory Assist Versus Noninvasive Pressure Support Ventilation in COPD Exacerbation: The NAVA-NICE Trial. Respir Care 2020; 65:53.</a></li><li><a class="nounderline abstract_t">Antón A, Güell R, Gómez J, et al. Predicting the result of noninvasive ventilation in severe acute exacerbations of patients with chronic airflow limitation. Chest 2000; 117:828.</a></li><li><a class="nounderline abstract_t">Duan J, Han X, Bai L, et al. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med 2017; 43:192.</a></li><li><a class="nounderline abstract_t">Yarnell CJ, Johnson A, Dam T, et al. Do Thresholds for Invasive Ventilation in Hypoxemic Respiratory Failure Exist? A Cohort Study. Am J Respir Crit Care Med 2023; 207:271.</a></li><li><a class="nounderline abstract_t">Poponick JM, Renston JP, Bennett RP, Emerman CL. Use of a ventilatory support system (BiPAP) for acute respiratory failure in the emergency department. Chest 1999; 116:166.</a></li><li><a class="nounderline abstract_t">Karnik AM. Noninvasive positive pressure ventilation: testing the bridge. Chest 2000; 117:625.</a></li><li><a class="nounderline abstract_t">Antonelli M, Conti G, Moro ML, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 2001; 27:1718.</a></li><li><a class="nounderline abstract_t">Esteban A, Anzueto A, Frutos F, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002; 287:345.</a></li><li><a class="nounderline abstract_t">Rodríguez A, Ferri C, Martin-Loeches I, et al. Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection. Respir Care 2017; 62:1307.</a></li><li><a class="nounderline abstract_t">Duan J, Chen L, Liang G, et al. Noninvasive ventilation failure in patients with hypoxemic respiratory failure: the role of sepsis and septic shock. Ther Adv Respir Dis 2019; 13:1753466619888124.</a></li><li><a class="nounderline abstract_t">Wunderink, RG, Hill, NS. Continuous and periodic applications of noninvasive ventilation in respiratory failure. Respir Care 1997; 42:394.</a></li><li><a class="nounderline abstract_t">Hill, NS. Complications of noninvasive positive pressure ventilation. Respir Care 1997; 42:432.</a></li><li><a class="nounderline abstract_t">Cook DT, Dahlhausen CM, Draper KR, Hilton LR. Pneumoperitoneum and PEG Dislodgement Secondary to Noninvasive Ventilation after PEG Tube Placement. Am Surg 2019; 85:1308.</a></li><li><a class="nounderline abstract_t">Iosifyan M, Schmidt M, Hurbault A, et al. "I had the feeling that I was trapped": a bedside qualitative study of cognitive and affective attitudes toward noninvasive ventilation in patients with acute respiratory failure. Ann Intensive Care 2019; 9:134.</a></li><li><a class="nounderline abstract_t">Tabbì L, Tonelli R, Comellini V, et al. Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trial. Minerva Anestesiol 2022; 88:815.</a></li><li><a class="nounderline abstract_t">Zhang R, Bai L, Han X, et al. Incidence, characteristics, and outcomes of delirium in patients with noninvasive ventilation: a prospective observational study. BMC Pulm Med 2021; 21:157.</a></li><li><a class="nounderline abstract_t">Confalonieri M, Gazzaniga P, Gandola L, et al. Haemodynamic response during initiation of non-invasive positive pressure ventilation in COPD patients with acute ventilatory failure. Respir Med 1998; 92:331.</a></li><li><a class="nounderline abstract_t">Mehta S, Jay GD, Woolard RH, et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med 1997; 25:620.</a></li><li><a class="nounderline abstract_t">Sharon A, Shpirer I, Kaluski E, et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 2000; 36:832.</a></li><li><a class="nounderline abstract_t">Bersten AD. Noninvasive ventilation for cardiogenic pulmonary edema: froth and bubbles? Am J Respir Crit Care Med 2003; 168:1406.</a></li><li><a class="nounderline abstract_t">Peter JV, Moran JL, Phillips-Hughes J, et al. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 2006; 367:1155.</a></li><li><a class="nounderline abstract_t">Ho KM, Wong K. A comparison of continuous and bi-level positive airway pressure non-invasive ventilation in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Crit Care 2006; 10:R49.</a></li><li><a class="nounderline abstract_t">Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008; 359:142.</a></li><li><a class="nounderline abstract_t">Alaya S, Mofredj A, Tassaioust K, et al. Acute Parotitis as a Complication of Noninvasive Ventilation. J Intensive Care Med 2016; 31:561.</a></li><li><a class="nounderline abstract_t">Muriel A, Peñuelas O, Frutos-Vivar F, et al. Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome: a marginal structural model causal analysis. Intensive Care Med 2015; 41:1586.</a></li><li><a class="nounderline abstract_t">Lewis K, Piticaru J, Chaudhuri D, et al. Safety and Efficacy of Dexmedetomidine in Acutely Ill Adults Requiring Noninvasive Ventilation: A Systematic Review and Meta-analysis of Randomized Trials. Chest 2021; 159:2274.</a></li><li><a class="nounderline abstract_t">Murgu SD, Pecson J, Colt HG. Bronchoscopy during noninvasive ventilation: indications and technique. Respir Care 2010; 55:595.</a></li><li><a class="nounderline abstract_t">Rzepka-Wrona P, Skoczynski S, Wrona D, Barczyk A. Inhalation Techniques Used in Patients with Respiratory Failure Treated with Noninvasive Mechanical Ventilation. Can Respir J 2018; 2018:8959370.</a></li></ol></div><div id="topicVersionRevision">Topic 126295 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16477416" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Time of non-invasive ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16438899" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Early use of non-invasive positive pressure ventilation for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24480997" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Use and outcomes of noninvasive positive pressure ventilation in acute care hospitals in Massachusetts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27513539" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Long-Term Survival Rate in Patients With Acute Respiratory Failure Treated With Noninvasive Ventilation in Ordinary Wards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18387700" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Out-of-hospital continuous positive airway pressure ventilation versus usual care in acute respiratory failure: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21951764" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Early out-of-hospital non-invasive ventilation is superior to standard medical treatment in patients with acute respiratory failure: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17967821" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema: physiological and clinical effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25269576" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prehospital noninvasive ventilation for acute respiratory failure: systematic review, network meta-analysis, and individual patient data meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25416493" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Continuous positive airway pressure and noninvasive ventilation in prehospital treatment of patients with acute respiratory failure: a systematic review of controlled studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23756329" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Assessment of the addition of prehospital continuous positive airway pressure (CPAP) to an urban emergency medical services (EMS) system in persons with severe respiratory distress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24342819" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Effect of out-of-hospital noninvasive positive-pressure support ventilation in adult patients with severe respiratory distress: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12907562" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Acute applications of noninvasive positive pressure ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Characteristics of pressure-targeted ventilators used for noninvasive positive pressure ventilation</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7697242" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : CO2 rebreathing during BiPAP ventilatory assistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8045145" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive pulmonary disease: determinants of success and failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11990923" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : New treatment of acute hypoxemic respiratory failure: noninvasive pressure support ventilation delivered by helmet--a pilot controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11904656" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Evaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14695719" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Noninvasive positive pressure ventilation using a helmet in patients with acute exacerbation of chronic obstructive pulmonary disease: a feasibility study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31687831" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Physiological Comparison of High-Flow Nasal Cannula and Helmet Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17039354" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Non-invasive ventilation in chronic obstructive pulmonary disease patients: helmet versus facial mask.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14564379" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Head helmet versus face mask for non-invasive continuous positive airway pressure: a physiological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15185070" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Noise exposure during noninvasive ventilation with a helmet, a nasal mask, and a facial mask.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18458874" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Helmet ventilation and carbon dioxide rebreathing: effects of adding a leak at the helmet ports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32059800" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32496521" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34413155" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Helmet noninvasive ventilation compared to facemask noninvasive ventilation and high-flow nasal cannula in acute respiratory failure: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36125473" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10890620" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Physiologic evaluation of noninvasive mechanical ventilation delivered with three types of masks in patients with chronic hypercapnic respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23263582" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Rescue therapy by switching to total face mask after failure of face mask-delivered noninvasive ventilation in do-not-intubate patients in acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19050635" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Interface strategy during noninvasive positive pressure ventilation for hypercapnic acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17194316" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Efficacy of a heated passover humidifier during noninvasive ventilation: a bench study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31673945" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical decision support recommending ventilator settings during noninvasive ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31651041" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intubation rate, duration of noninvasive ventilation and mortality after noninvasive neurally adjusted ventilatory assist (NIV-NAVA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7767523" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10470565" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : NIPPV: patient-ventilator synchrony, the difference between success and failure?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19183949" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Patient-ventilator asynchrony during non-invasive ventilation for acute respiratory failure: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10470568" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Patient-ventilator asynchrony during noninvasive ventilation: the role of expiratory trigger.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12918515" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : New things are not always Better: proportional assist ventilation vs. pressure support ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11719297" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Noninvasive proportional assist ventilation for acute respiratory insufficiency. Comparison with pressure support ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11889302" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Noninvasive proportional assist ventilation compared with noninvasive pressure support ventilation in hypercapnic acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12802487" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Noninvasive pressure support versus proportional assist ventilation in acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31641071" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Neurally-Adjusted Ventilatory Assist Versus Noninvasive Pressure Support Ventilation in COPD Exacerbation: The NAVA-NICE Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10713013" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Predicting the result of noninvasive ventilation in severe acute exacerbations of patients with chronic airflow limitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27812731" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36150166" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Do Thresholds for Invasive Ventilation in Hypoxemic Respiratory Failure Exist? A Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10424521" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Use of a ventilatory support system (BiPAP) for acute respiratory failure in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10712982" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Noninvasive positive pressure ventilation: testing the bridge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11810114" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11790214" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28698265" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31722614" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Noninvasive ventilation failure in patients with hypoxemic respiratory failure: the role of sepsis and septic shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Continuous and periodic applications of noninvasive ventilation in respiratory failure</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Complications of noninvasive positive pressure ventilation</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31775976" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pneumoperitoneum and PEG Dislodgement Secondary to Noninvasive Ventilation after PEG Tube Placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31792644" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : "I had the feeling that I was trapped": a bedside qualitative study of cognitive and affective attitudes toward noninvasive ventilation in patients with acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35708040" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33975566" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Incidence, characteristics, and outcomes of delirium in patients with noninvasive ventilation: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9616534" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Haemodynamic response during initiation of non-invasive positive pressure ventilation in COPD patients with acute ventilatory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9142026" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10987607" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14668249" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Noninvasive ventilation for cardiogenic pulmonary edema: froth and bubbles?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16616558" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16569254" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A comparison of continuous and bi-level positive airway pressure non-invasive ventilation in patients with acute cardiogenic pulmonary oedema: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18614781" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Noninvasive ventilation in acute cardiogenic pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26928643" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Acute Parotitis as a Complication of Noninvasive Ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25971392" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome: a marginal structural model causal analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33434496" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Safety and Efficacy of Dexmedetomidine in Acutely Ill Adults Requiring Noninvasive Ventilation: A Systematic Review and Meta-analysis of Randomized Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20420731" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Bronchoscopy during noninvasive ventilation: indications and technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29973963" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Inhalation Techniques Used in Patients with Respiratory Failure Treated with Noninvasive Mechanical Ventilation.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
